AI assistant
PFIZER INC — Director's Dealing 2021
Mar 1, 2021
29831_dirs_2021-03-01_8e25c101-1a20-4a17-98b0-dc961ce12c75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-25
Reporting Person: BOURLA ALBERT (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-25 | Common Stock | M | 163334.0000 | $22.8600 | Acquired | 245037.0000 | Direct |
| 2021-02-25 | Common Stock | F | 28221.0000 | $33.8200 | Disposed | 216816.0000 | Direct |
| 2021-02-25 | Common Stock | F | 105707.0000 | $34.7600 | Disposed | 111109.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-25 | Stock Appreciation Rights | $22.8600 | M | 163334.0000 | Disposed | 2021-02-25 | Common Stock (163334.0000) | Direct |
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 491626.0000 | Acquired | 2026-02-25 | Common Stock (491626.0000) | Direct |
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 424782.0000 | Acquired | 2028-02-25 | Common Stock (424782.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3720.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.